Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 USD | -0.74% | +1.50% | +15.38% |
May. 13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
May. 09 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bullish | Neutral | Bullish |
Resistance | 1.490 | 2.020 | 1.710 |
Spread/Res. | -9.40% | -33.17% | -21.05% |
Spread/Supp. | +2.27% | +42.11% | +23.85% |
Support | 1.320 | 0.9500 | 1.090 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- CLSD Stock
- Charts Clearside Biomedical, Inc.